Amferia

Fighting antibiotic resistance

  • CEO: Anand Kumar Rajasekharan
  • First investment year: 2020
  • Fund: West Sweden
  • Business sector: Life Science

Amferia

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia's core focus is preventive healthcare and wound care where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria.